This Brief focuses on the cancer therapy available till date, from
conventional drug delivery to nanomedicine in clinical trial. In
addition, it reports on future generation based nanotherapeutics and
cancer theranostic agent for effective therapeutic diagnosis and
treatment. Breast cancer was chosen as the model system in this review.
The authors give emphasis to multiple drug resistance (MDR) and its
mechanism and how to overcome it using the nanoparticle approach.